BATCH-8319 · filed

Regulation & Compliance

Innospec wins Regulatory & Compliance Excellence at first-ever CBIAs

Innospec claimed the Regulatory & Compliance Excellence category at the first Cosmetics Business Innovation Awards on 4 September 2026, with judge Emma Meredith citing its human-focused, non-animal safety methodologies as a credible alternative to traditional cosmetic ingredient

By Amara Osei · · 3 min read · 599 words

Composition

  1. Innospec won Regulatory & Compliance Excellence at the first CBIAs, announced 4 September 2026
  2. Judge Emma Meredith cited the supplier's human-focused safety methodologies as an ethical alternative to animal testing on cosmetic ingredients
  3. The CBIAs are B2B-focused, covering ingredients, packaging, contract manufacturing, technology, testing, and regulatory & compliance; fellow winners include Croda, Nuon Medical and Symrise
  4. More than 35 cosmetics players, including L'Oréal, LVMH and P&G, sit on the International Collaboration on Cosmetics Safety (ICCS)
  5. EU cosmetics animal-testing marketing bans run under Cosmetics Regulation (EC) No 1223/2009, in force since 2013

Innospec took the Regulatory & Compliance Excellence award at the inaugural Cosmetics Business Innovation Awards, recognised on 4 September 2026 for building human-focused safety methodologies that replace animal testing on cosmetic ingredients.

The B2B-focused CBIAs programme covers ingredients, packaging, contract manufacturing, technology, testing, regulatory and compliance. Other winners from this first cohort include Croda, Nuon Medical and Symrise, putting Innospec alongside the highest-profile suppliers operating in the personal care value chain.

What did Innospec actually win for?

Judge Emma Meredith singled out the supplier's use of human-relevant testing approaches to assess cosmetic ingredient safety and efficacy. In the award citation, Meredith said she was "impressed by their novel use of human-focussed methodologies to test the safety of cosmetics ingredients, providing an ethical alternative to animal testing."

That remit matters for formulators and compliance teams because the data generated under these methods can support safety dossiers without relying on in vivo animal studies — a route increasingly scrutinised under EU and UK frameworks where animal testing on finished cosmetics has been prohibited since 2013, with the marketing ban enforced through the Cosmetics Regulation (EC) No 1223/2009.

Why does a methodology prize matter to a procurement or compliance lead?

For brand owners, the award functions as a third-party validation signal. A supplier that can generate safety data accepted by regulators using non-animal approaches reduces:

  • The compliance workload tied to defending in vivo references
  • The risk of dossiers being rejected for ethics-based reasons in jurisdictions moving further away from animal data
  • The reformulation pressure that arises when an ingredient's animal-derived safety package falls out of favour

For ingredient buyers, the signal also acts as a marker for the next generation of safety substantiation — particularly relevant given ongoing industry alignment around the International Collaboration on Cosmetics Safety (ICCS), which counts more than 35 companies, including L'Oréal, LVMH and P&G, among its members.

What does the ruling change in practice?

In practical terms, very little for finished-product launches tomorrow. Innospec already runs an active collaboration with Unilever on safe ingredient use without animal testing, and the award formalises a regulatory posture that has been building for several years.

The wider payoff sits upstream. Meredith praised Innospec's "commitment to advancing regulatory acceptance of non-animal alternative methodologies, helping to shape and maintain robust, forward-looking regulatory frameworks that can benefit the industry in the long term."

That framing puts pressure on competing suppliers to match the bar. Watch for:

  • New OECD test guideline acceptances referencing Innospec-style approaches
  • Updates to SCCS Notes of Guidance citing human-relevant data
  • Brand-side RFP language shifting toward suppliers with validated non-animal safety packages

What should formulators track?

The "last resort" principle on animal testing remains the regulatory anchor across the EU and UK. Any supplier that can credibly bypass the need for that last resort gains a competitive edge in tender processes, particularly for retailers and brand owners with public-facing no-animal-testing commitments.

Innospec's win signals that B2B award juries — not just NGOs or regulators — now treat methodology as a distinct category of innovation, alongside ingredient chemistry and formulation performance. Procurement teams reviewing supplier scorecards should weight regulatory methodology capability accordingly.

The next data point to watch is how Innospec's award translates into published OECD or SCCS endorsements over the next 12 to 18 months, and whether competing ingredient houses disclose parallel human-focused testing programmes in upcoming industry filings.

The full judges' reveal of the Cosmetics Business Innovation Awards 2026 is available via the awards sign-up page.

via hpcimedia.com (Original)

Filed under

  • innospec
  • animal-testing-alternatives
  • cosmetic-regulatory-compliance
  • cbias
  • safety-substantiation

More from Amara Osei

Amara Osei

Show full bio

News editor covering media and advertising at INCI File.

89 articles

Cross-references · Related articles

« Previous articleNext article »

End of monograph · 3 min read